Quantcast
Channel: Europe Headlines on One News Page [United Kingdom]
Viewing all 65275 articles
Browse latest View live

Scrutinizing the Latest Approaches in the Sphere of Materials Science and Nanotechnology

October 31, 2018, 7:00 am
$
0
0
Conference Series Materials Science Conferences to be Held in 2019

SINGAPORE & LONDON (PRWEB) October 31, 2018

Since most of the very pressing scientific problems currently faced by humans are due to the limitations of materials, the field of Materials Science has seen a huge expansion in recent years. Currently the global market in Materials Science is projected to reach $6,000 million by 2020 and lodge a CAGR of 10.2% between 2015 and 2020 in terms of worth. The North American region remains the largest market, accompanied by Asia-Pacific. The European market is estimated to grow at a steady rate due to economic reforms in the region along with the expanding concern for the building insulation and energy savings.

The main aim of Materials Science Conferences is to provide an opportunity for the attendees to meet, interact, and exchange new ideas in Materials Science and Nanotechnology, and to initiate a dialogue between industry and the academia. This is especially important as the smooth transition of academic research into large scale industrial development is essential for any impactful innovation to reach the market.

Conference Series Ltd materials science summits focus on a plethora of topics such as Materials Science, Biomaterials, Nanotechnology, Smart Materials, Ceramics, Crystallography, and Nanostructures. The venues for these conferences include an eclectic mix of destinations across Europe, Asia, America, Middle East and Australia. These include some very beautiful cities like Rome, Paris, Athens, Madrid, Berlin, Toronto, Vancouver, Osaka, Singapore, Chicago, and many more. Renowned researchers, business experts, and renowned thinkers from around the world participate in these conferences. These programs include plenary lectures, poster presentations, symposia, workshops, young researcher competitions, panel discussions on a variety of topics.

Dr. Srinibabu Gedela, Founder & CEO of Omics International, states that conferences form the bedrock of any research as they open any piece of scientific work to constructive criticism by peers, making conferences a type of informal peer-review. He staunchly believes that conferences play a fundamental role in shaping scientific research.

In emulation of their previous meetings, the 100+ Materials Science meetings of 2019, conducted by the Conference Series extend a cordial welcome to all the scientists, researchers, corporate personnel, students, professors, and members from across the globe to share exciting results and advancements in the arena of Material Science and Nanotechnology. Reported by PRWeb 35 minutes ago.
↧
Search
↧

DoubleHorn Announces Reselling Agreement with Alibaba Cloud

October 31, 2018, 7:09 am
$
0
0
AUSTIN, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- DoubleHorn, a cloud solutions provider and cloud services brokerage, is proud to announce its agreement with Alibaba as an authorized reseller of Alibaba Cloud technology.

**The Significance Of Alibaba Cloud Agreement
**As a cloud brokerage firm, DoubleHorn offers a variety of options for customers looking to migrate their business to the cloud. DoubleHorn’s agreement with Alibaba Cloud now brings its total number of cloud provider agreements to six.

*“Having Alibaba Cloud as part of our portfolio offers even more choice at a competitive price point for customers exploring multi-cloud in alternative regions,”* said Uttam Reddy, DoubleHorn’s Senior Vice President of Marketing and Sales.

Partnering with Alibaba Cloud helps DoubleHorn go forward with future business opportunities.

**Alibaba’s Rapid Growth In Cloud Technology
**Alibaba Cloud is the fourth largest cloud provider in the world behind AWS, Azure, and Google Cloud as shown on the LIFTR Index and is growing at an astronomical rate of 113% year-over-year in revenue.

Not only has Alibaba Cloud expanded rapidly into the Asia-Pacific region but the cloud company has now extended its reach into Europe and North America.

With DoubleHorn, Alibaba Cloud has a US-based multi-cloud broker to leverage and grow its US market share, especially for US companies with a large compute storage or data presence in Australia, New Zealand, and the Pacific Rim.

For DoubleHorn, this agreement establishes an early presence as a US company partner with Alibaba Cloud.

**DoubleHorn’s Alibaba Cloud Report
**For more information on Alibaba Cloud, read Liftr’s comprehensive report highlighting opportunities, services, market share, revenue growth and more on the growing cloud giant.

*“We are excited to be an early partner with Alibaba Cloud in North America. As addressed in our recent report on Alibaba Cloud, they are showing rapid growth in a market full of opportunity,” *said Drew Bixby, Director of Technical Services at DoubleHorn.

As a leading cloud brokerage firm, DoubleHorn prides itself on offering choices for businesses looking to compare different providers. Companies looking to migrate to the cloud can visit DoubleHorn.com.

DoubleHorn is proud to now add Alibaba Cloud to the list of cloud providers and services it offers.

**About DoubleHorn:
**Austin, Texas-based DoubleHorn is a leading Cloud solutions provider and services broker founded in 2005. DoubleHorn is dedicated to helping companies navigate technology transformations using their Cloud brokerage and management platform. Learn more about DoubleHorn’s services.

CONTACT: Media Contact:
DoubleHorn
512-637-5200
media@doublehorn.com Reported by GlobeNewswire 26 minutes ago.
↧

Werner Enterprises to Participate in Two Investment Conferences

October 31, 2018, 7:19 am
$
0
0
OMAHA, Neb., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Werner Enterprises, Inc. (NASDAQ: WERN), one of the nation's largest transportation and logistics companies, announced that Derek J. Leathers, President and Chief Executive Officer, and John J. Steele, Executive Vice President, Treasurer and Chief Financial Officer, will participate in the following investment conferences in November 2018.*Stephens Investment Conference:* Tuesday, November 6, 2018, in New York City, New York, fireside chat presentation at 11:15 a.m. ET.

*Baird 2018 Global Industrial Conference: *Wednesday, November 7, 2018, in Chicago, Illinois, fireside chat presentation at 3:00 p.m. CT.

A live audio webcast and any related presentation materials for each of the events will be available on the conference date through the “Investors” link on the Werner website at www.werner.com. An archive will then be available on the Werner website during the 30-day period following each conference date.

The conference dates and times provided in this press release may be subject to change. Should any such change occur, Werner may update the information by giving notice on its website or through other methods of public disclosure. Please consult the Werner website before or on the conference date for any such updated notices.

Werner Enterprises, Inc. was founded in 1956 and is a premier transportation and logistics company, with coverage throughout North America, Asia, Europe, South America, Africa and Australia. Werner maintains its global headquarters in Omaha, Nebraska and maintains offices in the United States, Canada, Mexico and China. Werner is among the five largest truckload carriers in the United States, with a diversified portfolio of transportation services that includes dedicated; medium-to-long-haul, regional and expedited van; and temperature-controlled. The Werner Logistics portfolio includes truck brokerage, freight management,  intermodal, international and final mile services. International services are provided through Werner’s domestic and global subsidiary companies and include ocean, air and ground transportation; freight forwarding; and customs brokerage.

Werner Enterprises, Inc.’s common stock trades on the NASDAQ Global Select Market^SM under the symbol “WERN”. For further information about Werner, visit the company’s website at www.werner.com.

This press release, as well as the investor materials provided by and the oral public statements made by any Werner representative during the conference presentation and webcast announced in this press release, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on information presently available to Werner’s management and are current only as of the date made. Actual results could also differ materially from those anticipated as a result of a number of factors, including, but not limited to, those discussed in Werner’s Annual Report on Form 10-K for the year ended December 31, 2017. For those reasons, undue reliance should not be placed on any forward-looking statement. Werner assumes no duty or obligation to update or revise any forward-looking statement, although it may do so from time to time as management believes is warranted or as may be required by applicable securities law. Any such updates or revisions may be made by filing reports with the U.S. Securities and Exchange Commission, through the issuance of press releases or by other methods of public disclosure.

Contact:
John J. Steele
Executive Vice President, Treasurer
and Chief Financial Officer
(402) 894-3036 Reported by GlobeNewswire 16 minutes ago.
↧

Closing of the combination agreement between Container Finance Ltd Oy and CMA CGM completed

October 31, 2018, 7:19 am
$
0
0
Containerships plc - Stock Exchange Release 31 October 2018 at 16:15 (EET)

*Closing of the combination agreement between Container Finance Ltd Oy and CMA CGM completed*

The combination agreement between Container Finance Ltd Oy and CMA CGM, signed on 20.6.2018 and accepted by competition authorities on 22.10.2018, has been closed on 31.10.2018.   

Upon closing the agreement, Container Finance’s entire container logistics operations including mainly Containerships plc, but also Multi-link Terminals Ltd and CD Holding Oy will integrate CMA CGM’s intra-regional market offering in Europe and Mediterranean area.

The CMA CGM Group is one of leading maritime transportation companies in the world with a diversified network of shipping lines all around the globe. Containerships’ strong presence in Northern Europe and the Baltic Sea is very complementary to CMA CGM’s intra-Europe short sea abilities and strengthens both parties’ position in the European logistics market.

The combination will not affect the rights of Containerships’ bondholders. Containerships continues to develop routes and services to provide industry’s best customer experience.

Further information:
Containerships plc
CEO, Kari-Pekka Laaksonen
tel. +358 50 5502555, kari-pekka.laaksonen (at) containerships.fi

Distribution:
NASDAQ OMX Helsinki
www.containershipsgroup.com

About Containerships group: Containerships group is a full service, door-to-door provider of shortsea shipping and logistics solutions. It ensures safe and rapid cargo transport between Finland, Russia, the Baltic States, Continental Europe, the UK and Ireland as well as in the Mediterranean region between Turkey and North Africa. Containerships offers a choice of all standard and special containers, and complete coverage through a fleet of sea vessels, and road, railway and river container transportation modes. The net sales for 2017 was MEUR 227. Containerships plc’s senior secured callable bond loan has been listed on OMX Helsinki since 22 November 2017.

About CMA CGM group: The CMA CGM Group, led by Rodolphe Saadé, is a world leader of maritime transport. Its 509 ships serve more than 420 ports worldwide on the 5 continents. In 2017, they transported nearly 19 million of TEU (Twenty-feet Equivalent Units). CMA CGM experiences a continuous growth and never stops innovating to propose new maritime, logistical and inland solutions to its clients. The Group employs 34,000 collaborators in the world and 2,400 in Marseilles where is located its headquarters and is present in 160 countries via its network of 755 agencies. Reported by GlobeNewswire 16 minutes ago.
↧

An Iron Curtain of social views is still evident in Europe, poll shows

October 31, 2018, 7:23 am
$
0
0
Reported by Telegraph.co.uk 12 minutes ago.
↧
↧

Malaysia: Former Al-Qaeda, LeT Men Among Five Terror Suspects Arrested

October 31, 2018, 10:26 pm
$
0
0
By Zam Yusa and Ali Nufael

Malaysia arrested five suspected militants in counter-terrorist raids since mid-October, including a former member of the South Asian extremist group Lashkar-e-Taiba (LeT) and an ex-field operative of al-Qaeda, police said Wednesday.

A 50-year-old Egyptian who had worked as an executive with a Kuala Lumpur-based advertising company was arrested on Oct.13 outside the country’s capital, national police chief Mohamad Fuzi Harun said.

“The suspect was a member of the al-Qaeda militant group during his stay in Afghanistan from 1988 to 1993,” Fuzi said in a statement. “He also met with Osama bin Laden, the former leader of al-Qaeda.”

The suspect, who entered Malaysia with his wife in May this year, told investigators he had been arrested previously in Canada and Egypt for using fake travel documents, which he also used to enter Azerbaijan and Pakistan in the past, Fuzi said.

The Egyptian had also been imprisoned in his home country for terror activities, Fuzi said. He did not identify the suspect.

“The man was not cooperative with investigators at the moment,” a high-ranking government source told BenarNews.

Authorities have not seen evidence that the suspect had denounced his involvement with the global militant organization, the source said.

“We are afraid that Malaysia will become a terror organization’s base. Al-Qaeda, unlike the IS, is good at making long-term plans,” the source said, using the other acronym for Islamic State.

He cited the meeting of al-Qaeda terrorists who met in 1999 in Kuala Lumpur as they plotted the Sept. 11, 2001 attacks against the United States. The four coordinated terror attacks, which involved hijacked planes, killed almost 3,000 people and injured 6,000 others.

In 2000, the source said, high-level al-Qaeda members also met in Kuala Lumpur to plan the bombing on that year of the U.S. Navy ship USS Cole in Yemen, killing 17 American sailors and injuring 39 others. Some of the attendees in that meeting were hijackers of the plane that was flown into the Pentagon in the 9/11 attacks, he said.

That meeting was organized by Malaysian Yazid Sufaat, a former army captain, believed to be one of al-Qaeda’s anthrax researchers. Malaysian authorities arrested Yazid in 2001, released him in 2008 and was rearrested in 2013 under the Security Offences (Special Measures) Act for incitement of terrorist acts.

Apart from the Egyptian, the counter-terror agents also arrested a 31 year-old Pakistani with suspected links to the South Asian militant group Lashkar-e-Taiba (LeT), Fuzi said.

He said a 31-year-old man, who was only identified as a Middle Eastern, was arrested after he had allegedly posted Facebook comments threatening to kill a foreign ambassador.

Two Malaysians, aged 32 and 40, were also arrested, he said. All of the suspects were detained separately in Kuala Lumpur, Selangor, Perak and the Borneo state Sabah between Oct. 13 and Oct. 26, the police chief said.

Investigators said the Malaysians were believed to have channeled funds to slain Malaysian IS recruiter Muhammad Wanndy Mohamed Jedi and another top Malaysian militant, Muhamad Fudhail Omar, who was believed killed in Syria last year, and also to the Abu Sayyaf, a group of militants operating in the southern Philippines.

Four of the suspects were detained under the Security Offenses (Special Measures) Act 2012 while the Pakistani was arrested on charges of violating the country’s Immigration Act.

**Analyst: ‘It’s a residual effect’**

A deradicalization expert told BenarNews that the presence of former al-Qaeda militants in nations outside of their home country was expected.

“It’s a residual effect of the phenomenon of militants who were active somewhere else, like Afghanistan,” said Ahmad el-Muhammady, a political science lecturer at the International Islamic University of Malaysia.

After their early activities, Ahmad said, militants would want to seek safe sanctuaries. Muslim-majority Malaysia, being an open country with friendly citizens, fits the bill, he said.

“Stringent security measures at the border and stronger intelligence cooperation with countries in the region and others, such as the Middle East and Europe, are needed to prevent the entry of foreign militants,” he said.

**First arrest of Lashkar-e-Taiba in Malaysia, analyst says **

A South Asian terrorism analyst told BenarNews the case involving the Pakistani could be unprecedented in Malaysia.

“I believe it’s the first such a case in Malaysia,” said Faran Jeffery, deputy director of the Islamic Theology of Counter Terrorism, a London-based think tank.

Lashkar-e-Taiba, which literally means the Army of the Righteous, is one of the largest and most active militant organizations in South Asia, operating mainly in Pakistan.

India blames the Pakistan-based LeT for several attacks on its soil, including the 2001 assault on the Indian Parliament that claimed 14 lives and the 2008 Mumbai attack.

LeT, formed in 1987 with funding from al-Qaeda, claims to be primarily fighting to “liberate” Muslims living in Indian Kashmir, where its cadres routinely target security forces. It has been designated by the Australian, U.S. and Indian governments as a terrorist organization. Reported by Eurasia Review 58 minutes ago.
↧

Europe Edition: Yemen, Indonesia, Whitey Bulger: Your Thursday Briefing

October 31, 2018, 9:58 pm
$
0
0
Here’s what you need to know to start your day. Reported by NYTimes.com 1 hour ago.
↧

'Fish are vanishing'

October 31, 2018, 10:08 pm
$
0
0
'Fish are vanishing' Symbol caption Mor Ndiaye is anxious about how he’ll live on on account of depleting fish shares International trawlers and an increasing fishmeal business are an increasing number of threatening the livelihood of Senegalese fishermen, forcing many emigrate to Europe, writes the BBC’s Alfonso Daniels. Mor Ndiaye, 34, has lived all his existence in St … Reported by The News Articles 1 hour ago.
↧
Search

Uefa plans heavyweight defence against Fifa shake-up

October 31, 2018, 10:02 pm
$
0
0
Scudamore and Agnelli to push Europe’s interests in proposed $25bn tournament overhaul Reported by FT.com 1 hour ago.
↧
↧

'I just want to reunite her with her family' - deceased woman is still not identified after one year

October 31, 2018, 10:32 pm
$
0
0
A NEW campaign is being launched across the UK and Europe to discover the identity of a woman whose body was washed up in a cove. Reported by The Argus 52 minutes ago.
↧

Saudi Arabia And Iran: When It Comes To Exiles, The Pot Calls The Kettle Black – Analysis

October 31, 2018, 10:26 pm
$
0
0
If Saudi Arabia is under pressure to give chapter and verse on the killing of journalist Jamal Khashoggi in its consulate in Istanbul, Iran risks straining relations with Europe at a time that it needs European support the most by targeting ethnic rights activists.

Mr. Khashoggi’s murder has focused attention on Saudi harassment and intimidation of dissidents as part of the kingdom’s effort to silence critical voices. The Saudi campaign had little geopolitical significance until Mr. Khashoggi’s killing.

By contrast, Iran’s long history of targeting ethnic rights activists, including Iranians of Arab descent and Kurds, has long been rooted in the Islamic republic’s belief that they enjoy the support of the United States, Saudi Arabia and Israel in a bid to destabilize the country.

If Saudi Arabia has suffered severe reputational damage with the killing of Mr. Khashoggi and could face sanctioning for the first time in its history, Iran, long struggling to polish its tarnished image, could face sanctioning by Europe at a moment that it needs the Europeans the most.

In the latest Iranian incident, Danish Prime Minister Lars Lokke Rasmussen and intelligence chief Finn Borch Andersen are calling for European Union sanctions after they discovered a plot to kill Danish residents associated with the Arab Struggle Movement for the Liberation of Ahvaz (ASMLA), an Iranian Arab group.

The plot, together with at least two other incidents in Europe in the last year, complicates European efforts to salvage a 2015 international agreement to curb Iran’s nuclear program after the United States withdrew from the deal and imposed crippling sanctions on Iran despite Iran’s denials of involvement.

The alleged Danish plot came to a head when authorities in late September closed bridges into Copenhagen and suspended train operations in connection with the case. Mr. Andersen said that Norway had since extradited to Denmark a Norwegian national of Iranian descent who was seen taking pictures of a the Danish home of an ASMLA leader.

ASMLA strives for independence of Iran’s south-eastern oil-rich province of Khuzestan that is home to Iran’s ethnic Arab community and borders on Iraq at the head of the Gulf.

Two other groups, the Islamic State and the Ahvaz National Resistance, claimed responsibility in September for an attack on a Revolutionary Guards parade in the Khuzestan capital of Ahwaz in which 29 people were killed and 70 others wounded.

Iranian officials blamed the United States and its allies, Saudi Arabia, the United Arab Emirates and Israel for the attack.

Iran at the time summoned the ambassadors of the Netherlands, Denmark and Britain to protest the three countries’ hosting of Iranian ethnic rights militants.

The Danish plot followed the killing by unidentified gunmen in the Netherlands in November 2017 of Ahmad Mola Nissi, another ASMLA leader. Shot dead on a street in The Hague, Mr. Mola Nissi died the violent life he was alleged to have lived.

A 52-year-old refugee living in the Netherlands since 2005, was believed to have been responsible for attacks in Khuzestan in 2005, 2006 and 2013 on oil facilities, the office of the Khuzestan governor, other government offices, and banks.

Together with Habib Jaber al-Ahvazi also known as Abo Naheth, another ASMLA activist, Mr. Mola Nissi focussed in recent years on media activities and fund raising, at times creating footage of alleged attacks involving gas cylinder explosions to attract Saudi funding, according to Iranian activists.

Mr. Mola Nissi was killed as he was preparing to establish a television station backed by Saudi-trained personnel and funding that would target Khuzestan.

The Netherlands has emerged in recent years as a hub for Iranian activists alongside Britain.

A group of exile Iranian academics and political activists, led by The Hague-based social scientist Damon Golriz, announced in September the creation of a group that intends to campaign for a liberal democracy in Iran under the auspices of Reza Pahlavi, the son of the ousted Shah of Iran who lives in the United States.

Compounding the fallout of Iran’s targeting of activists, is last month’s expulsion by France of an Iranian diplomat accused of being part of a plot to bomb a rally in Paris organized by the Mujahedeen-e-Khalq, a Saudi-backed Iranian exile group that calls for regime change in Tehran. The diplomat was among six people arrested for allegedly plotting the bombing.

The Mujahedeen enjoy the support of prominent Western politicians like US President Donald J. Trump’s national security advisor, John Bolton, his personal lawyer, Rudolph Giuliani, and Saudi Arabia’s former intelligence chief, Prince Turki al-Faisal. Mr. Giuliani addressed the targeted rally.

U.S. officials say Iran plotted to attack the group’s massive base in Albania in March.

Support for the Mujahedeen has figured prominently in broadcasts of UK-based television station Iran International that according to The Guardian is owned by a secretive offshore entity with close links to Saudi crown prince Mohammed bin Salman.

The Guardian reported that Saud al-Qahtani, Prince Mohammed’s menacing information czar who was one of several senior Saudi officials removed from office in the wake of the killing of Mr. Khashoggi, was among the station’s main funders.

“I can say that Iran International TV has turned into a platform … for ethnic partisanship and sectarianism,” The Guardian quoted a source as saying.

The Danish, French and Dutch incidents suggest that Iran takes serious indications that Saudi Arabia is considering attempting to destabilize the Islamic republic by stirring unrest among its ethnic minorities.

Mr. Bolton advocated a similar strategy before becoming Mr. Trump’s national security advisor.

Iran has been the target in the past year of various insurgent groups believed to have Saudi support, sparking repeated clashes with Iranian security forces and the interception of Kurdish, Baloch and other ethnic rebels.

Iranian foreign minister Mohammad Javad Zarif arrived in Islamabad this week on an unscheduled visit to discuss the recent kidnapping of at least 12 Iranian border and Revolutionary Guards believed to have been abducted on the Iranian side of the Pakistani-Iranian border by Jaish al-Adl, a Pakistani group that often issues its statements in Arabic rather than Baloch, Urdu or Farsi.

As the United States prepared to next week impose a new round of sanctions against Iran, Secretary of State Mike Pompeo used the Iranian attacks in Europe to weaken European rejection of the US move.

“For nearly 40 years, Europe has been the target of Iran-sponsored terrorist attacks. We call on our allies and partners to confront the full range of Iran’s threats to peace and security,” Mr. Pompeo tweeted. Reported by Eurasia Review 58 minutes ago.
↧

Global Aroma Ingredients Market Will Reach USD 3.05 Billion By 2024: Zion Market Research

October 31, 2018, 10:28 pm
$
0
0
According to the report, the global aroma ingredients market was valued at around USD 2.24 billion in 2017 and is expected to reach approximately USD 3.05 billion by 2024, growing at a CAGR of slightly above 4.5% between 2018 and 2024.

New York, NY, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled *“Aroma Ingredients Market by Type (Synthetic Ingredients and Natural Ingredients) and by Application (Fine Fragrances, Toiletries, and Cosmetics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017-2024’’*. According to the report, the global aroma ingredients market was valued at around USD 2.24 billion in 2017 and is expected to reach approximately USD 3.05 billion by 2024, growing at a CAGR of slightly above 4.5% between 2018 and 2024.

Chemicals majorly derived from petroleum or other natural raw materials are used in various products, such as cosmetics, detergents, and soaps, among others, to give them the required fragrance. These fragrance ingredients are also used as stabilizers and antioxidants in many industries. Their increasing use in the spa industry for aromatherapy has gained momentum in the past five years, due to improved lifestyle choices and an increase in the disposable income of people.

*Browse through 55 Tables & 20 Figures spread over 110 Pages and in-depth TOC on “Global Aroma Ingredients Market: By Type, Size, Industry Share, Applications, Trends, Analysis and Forecast, 2017-2024”.*

*Request Free Sample Report of Global Aroma Ingredients Market Report @ *https://www.zionmarketresearch.com/sample/aroma-ingredients-market

Cosmetics products usually consist of decomposable constituents that might deteriorate due to the presence of the microbes, which, in turn, causes odor. Aromatic ingredients helping to overcome the odor problem in beauty products. Various technical advancements are being done in the extraction process of aroma ingredients along with other development techniques to boost this market growth. Rising disposable income and better access to quality brands of consumers, due to an effective supply chain, are driving this market growth. The Asia Pacific region is estimated to have the highest market share, due to the huge demand from the end-users of aroma ingredients. 

The major restraining factor pertaining to the global aroma ingredients market is their high production and R&D costs. However, the high growth potential of emerging economies, such as India and China, is likely to provide many opportunities for the key players operating in the global aroma ingredients market.

*Download Free Report PDF Brochure: *https://www.zionmarketresearch.com/requestbrochure/aroma-ingredients-market

The global aroma ingredients market is segmented based on type and application. The cosmetics segment is likely to be the most dominant in the global aroma ingredients market in the upcoming years. Increase in the use of cosmetics by people of all age groups is anticipated to drive the demand for aroma ingredients in the forecast timeframe.

The regional segmentation of the global aroma ingredients market includes Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. The Asia Pacific aroma ingredients market is expected to witness a significant rate of growth over the forecast timeframe. Countries such as India, China, and Japan have a huge customer base for cosmetics where these ingredients are largely used. The key players in the market are also investing excessively in R&D, which, in turn, might boost the demand for aroma ingredients in this region. Moreover, other products such as detergents, soaps, and essential oils are extensively fuelling the demand for aroma ingredients in the region.

*Request for The Discount on This Report:* https://www.zionmarketresearch.com/requestdiscount/aroma-ingredients-market

Europe is likely to witness a substantial growth for aroma ingredients in the future, due to the favorable regulatory inclinations in the region. The government is supporting various R&D projects in the region to boost the growth of the aroma ingredients market. Stern regulations related to the processing of cosmetic products have encouraged production of quality beauty products in Europe.

The North American aroma ingredients market is expected to witness a substantial growth during the forecast timeframe. Growth in the personal care industry is the major factor driving the growth of this market in North America. The demand for luxury aroma products in the region is one of the key factors boosting the growth of the aroma ingredients market.

Browse the full *"Aroma Ingredients Market: by Type (Synthetic Ingredients and Natural Ingredients) and by Application (Fine Fragrances, Toiletries, and Cosmetics):  Global Industry Perspective, Comprehensive Analysis and Forecast, 2017-2024"* report at https://www.zionmarketresearch.com/report/aroma-ingredients-market

The Middle East and African region can be seen as one of the most potential regions for the beauty industry due to the youth population, high levels of disposable income, and impressive growth rates. Thus, this region is likely to witness substantial growth in the aroma ingredients market during the forecast timeline.

Some major players operating in the global aroma ingredients market areGivaudan, Firmenich SA, International Flavors & Fragrances Inc. (IFF), Symrise, Bell Flavors & Fragrances, Ogawa & Co., Ltd., Huabao, Solvay, Kao Corporation, and Robertet SA, among others.

*Inquire more about this report before purchase @ *https://www.zionmarketresearch.com/inquiry/aroma-ingredients-market

*This report segments the global aroma ingredients market as follows:*

*Global Aroma Ingredients Market: Type Analysis*

· Synthetic Ingredients
· Natural Ingredients

*Global Aroma Ingredients Market: Application Analysis*

· Fine Fragrances
· Toiletries
· Cosmetics 

*Global Aroma Ingredients Market: Regional Analysis*

· North America

· The U.S.

· Europe

· UK
· France
· Germany

· Asia Pacific

· China
· Japan
· India

· Latin America

· Brazil

· The Middle East and Africa

*Related Reports:*

· *Chemical Tankers Market:* https://www.zionmarketresearch.com/report/chemical-tankers-market
· *Fiber Reinforced Composites (FRC) Market: *https://www.zionmarketresearch.com/report/fiber-reinforced-composites-market
· *Agricultural Adjuvants Market:* https://www.zionmarketresearch.com/report/agricultural-adjuvants-market
· *Clear Brine Fluids Market:* https://www.zionmarketresearch.com/report/clear-brine-fluids-market
· *Specialty Resins Market: *https://www.zionmarketresearch.com/report/specialty-resins-market  

*About Us:*

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

*Follow Us LinkedIn: *https://www.linkedin.com/company/zion-market-research
*Follow Us Twitter: *https://twitter.com/zion_research

*Blog:* http://www.intenseresearch.com | http://www.mrsresearchgroup.com | http://www.marketresearchtrade.com | https://qyresearchgroup.com | http://marketnreports.com | https://zmrnewsjournal.us | http://www.e-marketresearch.com

*Contact Us:*

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
*Email:* sales@zionmarketresearch.com

*Website:* https://www.zionmarketresearch.com

*Blog:* http://zmrblog.com Reported by GlobeNewswire 57 minutes ago.
↧

Domestic Violence Widely Accepted In Most Developing Countries

October 31, 2018, 10:26 pm
$
0
0
Societal acceptance of domestic violence against women is widespread in developing countries, with 36 per cent of people believing it is justified in certain situations.

Using Demographic and Health Surveys conducted between 2005-2017, researchers at the University of Bristol analysed data from 1.17 million men and women in 49 low- and middle-income countries.

These findings, published in the journal PLOS ONE today [31 October] and funded by the Economic and Social Research Council (ESRC) Future Research Leaders award, will help shape national and international strategies to prevent domestic violence.

Surveys measured whether people thought a husband or partner was justified in beating his wife or partner is she goes out without telling him, argues with him, neglects the children, suspects her of being unfaithful, refuses to have sex, or burns the food.

On average, 36 per cent of people thought it was justified in at least one of these situations. Attitudes towards domestic violence varied significantly across the 49 countries with only three per cent of people justifying it in the Dominican Republic, in the Caribbean, compared to 83 per cent in Timor-Leste, South East Asia.

Overall, the societal acceptance of domestic violence was higher in South Asia with nearly half the population (47 per cent) justifying it and in Sub-Saharan Africa (38 per cent), compared with Latin America and the Caribbean (12 per cent), Europe and Central Asia (29 per cent).

In 36 of the 49 countries, mainly in South East Asia and Sub-Saharan Africa, women were more likely to justify the behaviour than men.

Country-level factors, especially the political environment, played an important role in the acceptance of domestic violence. For example, this attitude of acceptance was more prevalent in countries which have experienced frequent and severe political conflict within the past five years.

Furthermore, the societal acceptance of domestic violence among men was lower in countries with more democratic regimes.

People in countries where women had more economic rights were less likely to justify domestic violence. These findings suggest that expanding women’s economic rights can serve to challenge existing social norms around gender roles and the expectations of women and men.

Dr LynnMarie Sardinha, an ESRC Research Fellow in Domestic Violence and Health at the University of Bristol, led the research. She said: “This is the first study of its kind and the insights it gives us into people’s attitudes towards domestic violence in the Global South and the influence of country-level factors and environment are invaluable if we’re to tackle this global problem.

“The widespread justification of domestic violence by women in highly patriarchal societies suggests women have internalised the idea that a husband who physically punishes his wife or verbally reprimands her has exercised a right that serves her interest. They perceive this behaviour as legitimate disciplining, rather than an act of violence.

“Our findings highlight the need for tailored, geographically-differentiated and gender specific interventions targeting acceptance of domestic violence. There is need for much greater focus on addressing the acceptance of domestic violence through targeted initiatives in societies affected by political conflict. Although domestic violence is exacerbated during and after armed conflict it’s prevention in these societies has received little attention.

“Interestingly, our findings suggest that the commonly-used measures of countries’ gender quality scores, for example, women’s labour force participation, and number of seats held by women in national parliament did not significantly influence society’s acceptance of domestic violence. This highlights the need for international domestic violence prevention policies to consider that a sole focus on narrowly defined economic or political ’empowerment’ alone are not sufficient in challenging existing discriminatory gender norms.

“Given that, as estimated by the World Health Organisation, 30 per cent of women globally have experienced physical or sexual violence from an intimate partner at least once in their lifetime, the prevention of domestic violence is both urgent and vital.

“Domestic violence has serious consequences for women’s physical, mental, sexual and reproductive health, negatively impacts on the well-being of children and families and has implications for wider society’s economic and social development.”

This project resulted in the construction of a first-of-its-kind global meta-database on societal attitudes to domestic violence, and a comprehensive range of diverse high quality internationally comparable socio-economic, political and legislative metadata from UN sources and other topic-specific databases.

Researchers hope the findings will inform the development of effective prevention programmes, targeting the factors which lead to domestic violence being accepted by different societies.

Several multilateral organisations, including the World Health Organisation and the United Nations, have already expressed an interest in using the data to help monitor its goal of achieving gender equality and empowering all women and girls (goal five of the UN Sustainable Goals Agenda to achieve a better and more sustainable future for all) that includes the elimination of all forms of violence against women and girls. Reported by Eurasia Review 58 minutes ago.
↧
↧

Protectionism Was Threatening Global Supply Chains Before Trump – Analysis

October 31, 2018, 10:42 pm
$
0
0
Protectionism Was Threatening Global Supply Chains Before Trump – Analysis President Trump’s protectionism has a distinctive focus on disrupting US access to global supply chains. This column reveals that the major economies had in fact begun to impose additional trade protection on intermediate inputs even prior to 2016. New barriers targeting cross-border supply chains simply arose through policies aside from headline tariffs. Some of this new protection has also already spread beyond China’s trade and begun to cover exports from other countries. These results, combined with more recent policy actions, widen the possibility of a negative protectionist impact on the global sourcing of parts and components.

By Chad Bown*

The scale of President Donald Trump’s protectionism is itself striking: his new tariffs in 2018 alone cover roughly 12% of US imports. But a second distinguishing feature is the protection’s distinctive focus on disrupting US access to global supply chains (Krugman 2018, Baldwin 2018). Trump’s tariffs on $250 billion of US imports from China have disproportionately targeted intermediate inputs. His trade restrictions on nearly $50 billion of imports of steel and aluminium will ultimately raise costs for US-based companies that rely on these metals, an especially poignant point for aluminium, where 97% of US jobs are in consuming industries.^1

Trump’s approach runs counter to the strategy that governments have adopted almost globally in recent decades: keep tariffs on inputs low. This facilitates domestic access to foreign-produced components and contributes to the competitiveness of local industry. Indeed, supply chains expanded across borders considerably during this period when countries erected low barriers on imported intermediates and took on legal commitments to keep them low via international trade and investment agreements (Johnson and Noguera 2017, Osnago et al. forthcoming).

But in Bown (2018b) I present new evidence that suggests that this is not the entire story. Hidden behind unchanging tariff policies, governments had begun to use other types of restrictions to curtail trade in intermediate inputs. It was taking place even before Donald Trump and not only in the US.

*There is no evidence that governments have changed their applied most-favoured nation tariffs to target supply chains*

Over recent decades, governments have typically applied lower tariffs to imports of capital equipment and intermediate inputs than to imports of final goods. For the period since 1995, Figure 1 documents this for the Group of 20 (G20) economies’ average applied most-favoured nation (MFN) tariffs.^2 These tariffs are the most important policy to begin such an analysis, since most of world trade takes place under WTO rules and is outside of the tariff preferences granted under free trade agreements.^3

*Figure 1* Simple average MFN applied tariffs 1995-2015, by Import product category

a) G20 high-income

b) G20 emerging

Notes: Simple average applied MFN tariff constructed from 6-digit Harmonized System data. Final, intermediate, and capital goods are taken from Broad Economic Category (BEC) definitions.
Source: Bown (2018b, Figure 2).

The rank ordering of tariffs across product categories is clear: on average, countries impose lower tariffs on capital equipment than on intermediates, which are much lower than those applied on imports of final goods, like consumer items. The evidence of Figure 1 confirms earlier, cross-sectional research documenting the patterns of higher tariffs on final goods relative to intermediates arising even within industries (Bown and Crowley 2016). Finally, emerging economies also tend to apply higher tariffs than high-income economies across each category of products.

The main take-away for supply chains is that the seemingly ubiquitous ranking of higher applied MFN tariff protection for final goods relative to inputs did not budge in the lead-up to 2016.

*Yet countries have increasingly targeted imported inputs with other types of trade restrictions*

While applied MFN tariff rates set an important baseline, major economies have increasingly turned to other trade policies when needing to make short-term product- and country-specific changes in protection. In the two decades prior to 2016, they commonly did so by imposing restrictions under the temporary trade barrier (TTB) policies of antidumping, countervailing (anti-subsidy) duties, or safeguards.^4

And with respect to supply chains, a detailed examination of the TTB policies tells a far different story. Figure 2 illustrates the share of imports covered by the cumulative application of trade restrictions in place under these policies in each year over 1995-2016. Since governments frequently impose these restrictions as special duties set at prohibitively high levels, the figure relies on import coverage ratios to characterize levels of trade protection instead of average tariffs.^5

*Figure 2 *Temporary trade barrier import coverage, 1995-2016

a) G20 high-income, TTB coverage of imports from China

b) G20 high-income, TTB coverage of imports from non-China

c) G20 emerging,* TTB coverage of imports from China

d) G20 emerging,* TTB coverage of imports from non-China

Notes: Shares are trade-weighted import coverage ratios *Does not include TTBs applied by China or by Saudi Arabia.
Source: Bown (2018b, Figure 4).

Three pieces of evidence stand out from Figure 2.

· First, a new result is that the TTB protection covering imported intermediates is frequently higher than the TTB coverage of final goods. And since 2010, there has been an increase in TTB protection covering imported intermediate inputs relative to final goods. Overall, the consistent ranking of applied MFN tariffs summarised by Figure 1 is not apparent for the protection arising under TTB policies.
· Second, the figure confirms the well-established result that both high-income and emerging economies impose this type of trade protection disproportionately against China’s exports. Overall, roughly 6% of both high-income and emerging economy imports from China were covered by TTBs by 2016. TTBs covered less than 2% of imports from the rest of the world.
· Yet, third, governments applied TTBs on an increasing share of imports from countries aside from China between 2010 and 2016, including on intermediate inputs. This evidence is also new.

In summary, trade restrictions increasingly targeted cross-border supply chains, and they were pushing beyond China’s exports to hit global trade in parts and components. This phenomenon was arising across policy-imposing countries and even before the election and protectionist policies of Donald Trump.

*Other new barriers to supply chains and implications*

The causes of such changes to trade protection are not yet well understood. One contributor is likely related to China’s continued expansion of capacity and exports in sectors like steel and aluminium. Despite China being long-targeted by TTBs (see again Figure 2), its export expansion into third markets continued to lower world prices. The resulting trade diversion – e.g. the US importing more steel from Korea or Europe instead – likely contributed to additional protection spreading to cover imports from such third countries.^6

Yet, one important additional point is that the results illustrated by Figure 2 are not limited to the metals sector. The share of imported intermediates covered by TTB protection was higher in 2016 relative to 2010 for a number of industries, including electronics, transportation equipment, wood products, and prepared foodstuffs.^7

And of course, protection that may disrupt established supply chains has moved well beyond even these TTB policies of anti-dumping, anti-subsidy duties, and safeguards since 2016. Now notorious are the Trump administration’s special “national security” and “China unfair trade” tariffs that target inputs.^8 But consider even the administration’s push for modifications of the North American Free Trade Agreement. The automobile rules of origin requirements and labour value content provisions in the newly announced US-Mexico-Canada Agreement are also likely to curtail trade in intermediate inputs in the sector (Bown 2018d). Finally, outside the region, there is also the potential for the UK’s Brexit negotiations to result in new tariff and non-tariff barriers on pan-European trade in intermediate inputs (Vandenbussche et al. 2017).

The trade policy threat to cross-border supply chains is clearly on the rise. But somewhat surprisingly, many of its signs were apparent even before Trump.

*About the author:
* Chad Bown*, Reginald Jones Senior Fellow, Peterson Institute for International Economics; CEPR Research Fellow

*References*
Baldwin, R (2018), “Trump can’t fix a 21st century problem with 20th century thinking”, VoxEU.org, 27 September.

Bown, C P (2016), “Should the United States Recognize China as a Market Economy?” Peterson Institute for International Economics Policy Brief 16-24, December.

Bown, C P (2018a), “For Trump, it was a summer of tariffs and more tariffs. Here’s where things stand”, Washington Post, 17 September.

Bown, C P (2018b), “Trade Policy Toward Supply Chains After the Great Recession”, IMF Economic Review, forthcoming.

Bown, C P (2018c) “Trump’s Steel and Aluminum Tariffs Are Counterproductive. Here Are 5 More Things You Need to Know”, PIIE Trade and Investment Policy Watch, 7 March.

Bown, C P (2018d) “The 5 Surprising Things about the New USMCA Trade Agreement”, Washington Post, 9 October.

Bown, C P (2018e) “Donald Trump’s Solar and Washer Tariffs May Have Now Opened the Floodgates of Protectionism”, Washington Post 25 January.

Bown, C P and M A Crowley (2016) “The Empirical Landscape of Trade Policy”, Chapter 1 in K Bagwell and R W. Staiger (eds), The Handbook of Commercial Policy, vol 1A. Amsterdam, Elsevier, North Holland.

Bown, Chad P, Eujin Jung and Zhiyao Lu (2018) “Trump and China Formalize Tariffs on $260 Billion of Imports and Look Ahead to Next Phase”, PIIE Trade and Investment Policy Watch, 20 September.

Bown, Chad P and Soumaya Keynes (2018) “Aluminum Made in the USA”, Trade Talks Episode 50, PIIE, 10 August.

Johnson, Robert C. and Guillermo Noguera (2017) “A Portrait of Trade in Value Added over Four Decades”, Review of Economics and Statistics 99(5): 896-911.

Osnago, Alberto, Nadia Rocha, and Michele Ruta (forthcoming) “Deep Agreements and Vertical FDI: The Devil is in the Details”, Canadian Journal of Economics.

Krugman, Paul (2018) “How to Lose a Trade War”, New York Times, 7 July.

WTO (2011) World Trade Report 2011: The WTO and Preferential Trade Agreements: From Co-Existenceto Coherence. Geneva: WTO.

Vandenbussche, Hylke, William Connell, Wouter Simons (2017) “Global value chains, trade shocks and jobs: An application to Brexit” VoxEU.org, 27 November

*Endnotes*

[1] For more details on the aluminum industry, see Bown and Keynes (2018). For the Trump administration’s 2018 tariffs on China, see Bown et al. (2018). For its 2018 tariffs on steel and aluminum, see Bown (2018a).

[2] For trade policy purposes, the G20 is made up of Argentina, Australia, Brazil, Canada, China, European Union, India, Indonesia, Japan, Mexico, Russia, Saudi Arabia, South Africa, South Korea, Turkey, and the United States.

[3] Using 2007 data on preferential trade agreements, WTO (2011) estimated that 84 percent of world merchandise trade (not including intra-EU trade) was still taking place on an MFN basis.

[4] For a general introduction to TTB policies, see Bown and Crowley (2016).

[5] The average US antidumping duty in effect in 2015 against China was 81.4% and against non-China it was 54.3% (Bown 2016).

[6] See Bown (2018c) for US use of TTBs on steel over 1995-2017, which increasingly applied to imports from non-China as well.

[7] See Bown (2018b, Figure 5). As another example, the US application of a global safeguard on solar panels in 2018 followed a series of country-specific antidumping restrictions imposed since 2011 that had led to trade diversion (Bown 2018e).

[8] The special US tariffs on steel and aluminum were applied under Section 232 of the Trade Expansion Act of 1962 and the tariffs on $250 billion of imports from China were applied under Section 301 of the Trade Act of 1974. Reported by Eurasia Review 42 minutes ago.
↧

Premier League DOMINATES list of 20 clubs with most expensive season tickets in Europe

October 31, 2018, 11:08 pm
$
0
0
Premier League DOMINATES list of 20 clubs with most expensive season tickets in Europe THE Premier League truly is the most expensive league in Europe for match-going fans. Reported by Daily Star 16 minutes ago.
↧
Search

Q3 2018 Trading statement

October 31, 2018, 10:56 pm
$
0
0
Unless otherwise stated, comments below refer to Q3 performance.

*Highlights*

 • Organic revenue growth of 9.0% (9M: growth of 6.4%). Reported net revenue of DKK 17.6bn (9M: DKK 48.6bn).

 • Price/mix of +1% (9M: +1%).

 • Total organic volume growth of 7.6% (9M +4.9%).

• Continued growth in our international premium portfolio: Tuborg +11%, Carlsberg +9%, Grimbergen +15% and 1664 Blanc +49%.
   • Craft & speciality volume growth of 29%, alcohol-free brew volume growth in Western Europe of 58%.

*2018 Earnings expectations *

 • Organic operating profit growth of 10-11% (unchanged from announcement at 24 October 2018).

 • Translation impact on operating profit of around DKK -500m, based on the spot rates at 31 October (unchanged from announcement at 24 October 2018).

CEO Cees ’t Hart says: “We delivered a strong third quarter with all regions performing very well. Our craft & speciality portfolio and alcohol-free brews continued their good momentum, and in Asia Tuborg, Carlsberg and 1664 Blanc delivered strong growth rates. Results in the quarter were further boosted by the very good weather in Western Europe.

“We’re pleased that last week we were able to increase our full-year earnings expectations, and we feel confident that 2018 will show solid top-line growth, margin improvement and a healthy cash flow, whilst we have invested significant funds in our strategic priorities to drive the long-term growth of our business.”

*
Contacts*

Investor Relations:        
Peter Kondrup    +45 2219 1221    
Iben Steiness     +45 3327 1232

Media Relations:           
Kasper Elbjørn   +45 4179 1216      
Anders Bering    +45 4179 1217

The Carlsberg Group will present the results at a conference call today at 9.00 am CET (8.00 am GMT). Dial-in information and slide deck are available beforehand on www.carlsberggroup.com.

*Attachments*

· 09_UK_01112018_Q3 2018 Trading Statement
· Quarterly_financial_data_Carlsberg_Group Reported by GlobeNewswire 28 minutes ago.
↧

Roche announces EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia

October 31, 2018, 11:06 pm
$
0
0
· *Approval is based on randomised phase III MURANO study showing that fixed duration of treatment with Venclyxto plus MabThera is well tolerated and reduced risk of disease progression or death by 83% compared to a current standard of care*
· *New combination provides a chemotherapy-free option for treating people with chronic lymphocytic leukaemia whose disease has returned after previous treatment*

Basel, 1 November 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Venclyxto® (venetoclax) in combination with MabThera® (rituximab) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy.

"There are approximately 30,000 people living with chronic lymphocytic leukaemia in Europe, an incurable blood cancer that becomes harder to treat with each relapse," said Sandra Horning, MD, Roche's Chief Medical Officer and Head of Global Product Development. "We are pleased that, thanks to this approval, Venclyxto plus MabThera will provide a new chemotherapy-free option for people with previously treated chronic lymphocytic leukaemia, helping them to live longer without their disease progressing compared to a standard-of-care therapy."

This approval is based on results from the randomised phase III MURANO study which showed that a fixed duration of treatment with Venclyxto plus MabThera significantly reduced the risk of disease progression or death (progression-free survival [PFS] as assessed by investigators [INV], primary endpoint of the study) by 83% compared with bendamustine plus MabThera (BR), a current standard of care (HR=0.17; 95% CI 0.11-0.25; p
Venclyxto was previously granted conditional marketing authorisation in the EU in December 2016 as a single agent for the treatment of CLL in the presence of 17p deletion or TP53 mutation in people who are unsuitable for or have failed a B-cell receptor pathway inhibitor. Today's EU approval follows the US Food and Drug Administration approval in June 2018 of Venclexta® in combination with Rituxan® for the treatment of people with CLL or small lymphocytic lymphoma, with or without 17p deletion, who have received at least one prior therapy. Additional submissions of the MURANO data to health authorities around the world are ongoing.

Venclyxto is being developed by AbbVie and Roche. It is jointly commercialised by AbbVie and Genentech, a member of the Roche Group, in the United States, under the brand name Venclexta, and commercialised by AbbVie outside of the United States.

*About the MURANO Study
*MURANO (NCT02005471) is a phase III open-label, international, multicentre, randomised study evaluating the efficacy and safety of fixed duration Venclexta/Venclyxto (venetoclax) in combination with MabThera/Rituxan (rituximab) compared to standard of care bendamustine in combination with MabThera/Rituxan (BR) in patients with relapsed or refractory chronic lymphocytic leukaemia (CLL). Patients on the Venclexta/Venclyxto plus MabThera/Rituxan arm received six cycles of Venclexta/Venclyxto plus MabThera/Rituxan followed by Venclexta/Venclyxto monotherapy for up to two years total. Patients on the BR arm received six cycles of BR. The study included 389 patients with CLL who had been previously treated with at least one line of therapy. Patients were randomly assigned in a 1:1 ratio to receive either Venclexta/Venclyxto plus MabThera/Rituxan or BR. The primary endpoint of the study was progression-free survival (PFS) as assessed by investigator (INV). Secondary endpoints included overall survival (OS), overall response rate (ORR), complete response rate (with or without complete blood count recovery, CR/CRi), minimal residual disease (MRD) and safety.

*MURANO Study Results ^**
*Treatment arm* Venclexta/Venclyxto + MabThera/Rituxan
(n=194) Bendamustine +
MabThera/Rituxan
(n=195)
*PFS (primary endpoint as assessed by INV) *
*Median PFS* Not reached (NR) 17.0 months
*Number of events* 32 (16.5%) 114 (58.5%)
*Hazard Ratio* 0.17 (95% CI 0.11-0.25), p *Secondary endpoints (as assessed by INV)*
*ORR* 93.3% 67.7%
*CR/CRi* 26.8% 8.2%
*MRD negativity rate at end of combination treatment*
*Peripheral blood* *62.4%* *13.3%*
*Bone marrow* *15.5%* *1.0%*
*OS *
*Number of events * 15 27
*Hazard ratio * 0.48 (95% CI 0.25-0.90), p
                   *Data at median follow-up of 24 months

The most common adverse reactions (>=20%) of any grade in patients receiving Venclyxto in the combination study with MabThera were neutropenia, diarrhoea, and upper respiratory tract infection. Death occurred in 11% of people who received Venclexta/Venclyxto plus MabThera/Rituxan compared to 16% for BR.

*About Venclexta/Venclyxto (venetoclax)
*Venclexta/Venclyxto is a first-in-class targeted medicine designed to selectively bind and inhibit the B-cell lymphoma-2 (BCL-2) protein. In some blood cancers and other tumours, BCL-2 builds up and prevents cancer cells from dying or self-destructing, a process called apoptosis. Venclexta/Venclyxto blocks the BCL-2 protein and works to restore the process of apoptosis.

Venclexta/Venclyxto is being developed by AbbVie and Roche. It is jointly commercialised by AbbVie and Genentech, a member of the Roche Group, in the United States and by AbbVie outside of the United States. Together, the companies are committed to research with Venclexta/Venclyxto, which is currently being studied in clinical trials across several types of blood and other cancers.

In the United States, Venclexta has been granted four Breakthrough Therapy Designations by the FDA: in combination with Rituxan for people with relapsed or refractory chronic lymphocytic leukaemia (CLL); as a monotherapy for people with relapsed or refractory CLL with 17p deletion; in combination with hypomethylating agents (azacitidine or decitabine) for people with untreated acute myeloid leukaemia (AML) ineligible for intensive chemotherapy; and in combination with low-dose cytarabine for people with untreated AML ineligible for intensive chemotherapy.

Venclexta/Venclyxto is approved in more than 50 countries. Roche and AbbVie are currently working with regulatory agencies around the world to bring this medicine to additional eligible patients in need.

*About Chronic Lymphocytic Leukaemia
*Chronic lymphocytic leukaemia (CLL) is the most common type of leukaemia in the Western world.^ [1]
CLL mainly affects men and the median age at diagnosis is about 70 years.^ [2] In Europe, the incidence of all leukaemias is estimated to be almost 95,000 ^[3] and CLL is estimated to affect around one-third of all people newly diagnosed with leukaemia.^[1]

*About Roche in haematology
*For more than 20 years, Roche has been developing medicines that redefine treatment in haematology. Today, we are investing more than ever in our effort to bring innovative treatment options to people with diseases of the blood. In addition to approved medicines MabThera/Rituxan (rituximab), Gazyva®/Gazyvaro® (obinutuzumab), and Venclexta®/Venclyxto® (venetoclax) in collaboration with AbbVie, Roche's pipeline of investigational haematology medicines includes Tecentriq® (atezolizumab), an anti-CD79b antibody drug conjugate (polatuzumab vedotin/RG7596) and a small molecule antagonist of MDM2 (idasanutlin/RG7388). Roche's dedication to developing novel molecules in haematology expands beyond malignancy, with the development of Hemlibra® (emicizumab), a bispecific monoclonal antibody for the treatment of haemophilia A.

*About Roche
*Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.
All trademarks used or mentioned in this release are protected by law.*References
*[1] Wendtner CM, et al. Chronic lymphocytic leukemia. Onkopedia guidelines 2012 [Internet; cited 2018]. Available from: https://www.onkopedia-guidelines.info/en/onkopedia/guidelines/chronic-lymphocytic-leukemia-cll/@@view/html/index.html
[2] SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia (CLL) [Internet; cited 2018]. Available from: http://seer.cancer.gov/statfacts/html/clyl.html.
[3] Calculation for Europe:World Health Organization. GLOBOCAN 2012. [Internet; cited 2018]. Available from: http://gco.iarc.fr/today/fact-sheets-populations
*Roche Group Media Relations
*Phone: +41 61 688 8888 / e-mail: media.relations@roche-global.com
- Nicolas Dunant (Head)
- Patrick Barth
- Ulrike Engels-Lange
- Simone Oeschger
- Anja von Treskow
*Attachment*

· Roche-Media-Release_MURANO_EU_approval_EN.pdf Reported by GlobeNewswire 19 minutes ago.
↧
↧

Biocartis Group NV: Eight Idylla(TM) Performance Studies to be Presented at the Association for Molecular Pathology Conference in the US

October 31, 2018, 11:06 pm
$
0
0
PRESS RELEASE: 1 November 2018, 07:00 CEST/00:00 CDT
*Eight Idylla(TM) Performance Studies to be Presented at the 'Association for Molecular Pathology' Conference in the US*

*Mechelen, Belgium, 1 November 2018* - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the publication of eight Idylla(TM) performance study abstracts at the Association for Molecular Pathology ('AMP') conference, the leading meeting of professionals in the field of molecular diagnostics taking place between 1-3 November 2018 in San Antonio, Texas (US). The studies are performed by renowned US oncology key opinion leaders from the Memorial Sloan Kettering Cancer Center (New York), Dartmouth-Hitchcock Medical Center (New Hampshire), AstraZeneca and the University of Alabama. All abstracts again highlight excellent Idylla(TM) performance, showing high concordance with current testing methods in combination with the unique features of the Idylla(TM) platform, being its ease of use, fully automated workflow and short turnaround times.

The eight Idylla(TM) abstracts relate to performance studies of the Idylla(TM) MSI Mutation Assay (RUO^[1]), the Idylla(TM) EGFR Mutation Assay (RUO), the Idylla(TM) KRAS Mutation Assay (RUO) and the Idylla(TM) BRAF Mutation Assay (RUO), led by various US key opinion leaders from:

· The Memorial Sloan Kettering Cancer Center (New York, US):

· K. Nafa et al., Memorial Sloan Ketting Cancer Center, "Rapid Assessment of Microsatellite Instability Status using the Idylla(TM) MSI Test"
· M.E. Arcila et al., Memorial Sloan Ketting Cancer Center, "Ultra-Rapid EGFR Mutation Assessment in Lung Adenocarcinoma without Prior DNA Extraction"

· The Dartmouth - Hitchcock Medical Center (New Hampshire, US):

· C.M. Nicka et al., Dartmouth-Hitchcock Medical Center, "Detection of Microsatellite Instability in Endometrial Carcinoma Using the Novel Idylla(TM) MSI Assay"
· N.S. Maloney et al., Dartmouth-Hitchcock Medical Center, "Biocartis Idylla(TM) Cartridge-based Microsatellite Instability Assay Shows High Concordance with Immunohistochemical Analysis for Mismatch Repair Status in Colorectal Cancer"
· M. Rabie Al-Turkmani et al., Dartmouth-Hitchcock Medical Center, "Stat EGFR Mutation Detection in Fresh Lung Cancer Tissue Specimens Using Touch Preparation and the Idylla(TM) System"
· M. Rabie Al-Turkmani et al., Dartmouth-Hitchcock Medical Center, "Rapid EGFR Mutation Testing in Lung Cancer Tissue Samples Using a Fully Automated System and Single-use Cartridge"

· AstraZeneca:

· M. Kohlman et al., AstraZeneca, on the comparison of the Idylla(TM) EGFR Mutation Assay^1,[2] based on 79 clinical FFPE^[3] tissue samples

· The University of Alabama:

· D. Morlote et al, "Validation of FFPE Tissue Punches for Detection of KRAS and BRAF Mutations with the Idylla(TM) PCR-based Molecular Diagnostics Assay"

One of the Dartmouth-Hitchcock Medical Center abstracts is an EGFR testing study using limited fresh lung cancer tissue touch-preparation specimens^[4]  on Idylla(TM). Results showed complete concordance with NGS^[5] testing on all samples but with a total time-to-result^[6] of less than three hours compared to ± 5.5 days for NGS. This shows that with the ease of use and sensitivity of Idylla(TM), touch preparation samples may be used to rapidly detect actionable mutations while preserving tumor tissue for subsequent (NGS) processing and analysis. This approach provides fast turnaround times, which could open doors for timely management decisions for time-sensitive cancer cases while awaiting more comprehensive tumor genome profiling, such as with NGS.

Another innovative study abstract^[7] from the Memorial Sloan Kettering Cancer Center, one of the leading cancer centers in the US, used the Idylla(TM) MSI Assay (RUO) to determine MSI^[8] status. It showed overall high concordance of 96% compared to previously determined MSI status^[9] with large-panel targeted NGS data. The study indicates that the Idylla(TM) MSI Assay (RUO) offers a simple and fully automated solution to determine MSI status, providing rapid results that are highly concordant with other MSI testing approaches.

*Herman Verrelst, Chief Executive Officer of Biocartis, commented:* "We are very pleased with these eight studies conducted by key opinion leaders in the US who are using our Idylla(TM) products. These studies once again underline Idylla(TM)'s unique positioning, providing results faster and easier than existing testing methods without compromising on performance. As such, these studies could be an important driver in the further adoption of Idylla(TM) in the US market."

Biocartis organized a workshop with speakers from the Memorial Sloan Kettering Cancer Center during the AMP conference in San Antonio (Texas, US) on 31 October 2018, highlighting the value of the Idylla(TM) EGFR, BRAF and MSI Assays^7. For more information on the workshop, see the Biocartis website. The eight Idylla(TM) performance abstracts can be found here.

*--- END ---*
*More information: *
Renate Degrave
Manager Corporate Communications & Investor Relations
e-mail   rdegrave@biocartis.com
tel         +32 15 631 729
mobile   +32 471 53 60 64

*About Biocartis *
Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Biocartis' proprietary MDx Idylla(TM) platform is a fully automated sample-to-result, real-time PCR (Polymerase Chain Reaction) system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting. Biocartis launched the Idylla(TM) platform in September 2014. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs in oncology and infectious diseases. These areas represent respectively the fastest growing and largest segments of the MDx market worldwide. Today, Biocartis offers fifteen oncology tests and two infectious disease tests in Europe. More information: www.biocartis.com. Press Photo Library available here. Follow us on Twitter: @Biocartis_.

Biocartis and Idylla(TM) are registered trademarks in Europe, the United States and other countries. Biocartis trademark and logo and Idylla(TM) trademark and logo are used trademarks belonging to Biocartis. This press release is not for distribution, directly or indirectly, in any jurisdiction where to do so would be unlawful. Any persons reading this press release should inform themselves of and observe any such restrictions. Biocartis takes no responsibility for any violation of any such restrictions by any person. Please refer to the product labeling for applicable intended uses for each individual Biocartis product. This press release does not constitute an offer or invitation for the sale or purchase of securities in any jurisdiction. No securities of Biocartis may be offered or sold in the United States of America absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended.
* * **
*Forward-looking statements*
This press release may contain forward-looking statements. Such forward-looking statements are not guarantees of future performance. These forward-looking statements speak only as of the date of this press release. Biocartis expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release, except if specifically required to do so by law or regulation. You should not place undue reliance on forward-looking statements.
^1 Research Use Only, not for use in diagnostic procedures.

^[2] The study abstract can be found in the AMP Abstract Book available on https://amp18.amp.org/abstracts-posters/.

^[3] Formalin fixed, paraffin embedded.

^[4] Using touch preparation. Touch preparation samples were obtained from fifteen lung cancer tissue specimens in the pathology gross room shortly after resection. This involved making a single incision into the tumor body at room temperature using a scalpel blade and touching one 10 mm filter paper on each of the two sides of the inner tumor surface and holding it in position for approximately 3 seconds. The two filter papers were placed in an Idylla(TM) EGFR Mutation Assay cartridge (Research Use Only) and the cartridge was subsequently placed in the Idylla(TM) instrument for automated EGFR mutation analysis. The tumor tissue specimen was subsequently processed using standard pathology protocols for fixation, embedding and sectioning.  Idylla(TM) results were compared with those obtained by subsequent somatic mutation analysis by next-generation sequencing (NGS) using the Ion AmpliSeq 50-gene Cancer Hotspot Panel v2 (Thermo Fisher Scientific).

^[5] Next Generation Sequencing.

^[6] Including analysis time, for all Idylla(TM) samples.

^[7] K. Nafa et al., Memorial Sloan Ketting Cancer Center, "Rapid Assessment of Microsatellite Instability Status using the Idylla(TM) MSI Test", first published at AMP 2018, 1-3 November 2018, San Antonio (Texas, US).

^[8] MSI is the result of inactivation of the body's so-called DNA mismatch repair (MMR) system. Consequently, errors that normally spontaneously occur during DNA replication are no longer corrected, contributing to tumor growth and evolution. Current MSI testing methods rely on manual, lengthy and complex procedures involving amongst others obtaining and testing of a second reference sample.

^[9] Based on MSIsensor Score from large-panel targeted NGS data generated by MSK-IMPACT, MSI-PCR (Promega) and/or MMR IHC. The Idylla(TM) MSI Assay is Research Use Only, not for use in diagnostic procedures.   Reported by GlobeNewswire 19 minutes ago.
↧

ArcelorMittal completes transaction to acquire Ilva S.p.A. and launches ArcelorMittal Italia

October 31, 2018, 11:06 pm
$
0
0
1 November 2018 – ArcelorMittal (‘the Company’) announces that AM Investco Italy Srl (‘AM Investco’)’s transaction to acquire Ilva S.p.A. (‘Ilva’) has completed today.ArcelorMittal is the principal partner in AM Investco with a 94.4 per cent equity stake in the consortium, with Banca Intesa Sanpaolo holding 5.6 per cent. AM Investco’s lease and purchase agreement is effective from today (1 November 2018).

Following completion of the transaction, ArcelorMittal has now assumed full management control of Ilva, which will form a new business cluster within ArcelorMittal Europe - Flat Products and be known as ArcelorMittal Italia.

*Commenting, Lakshmi Mittal, Chairman and CEO, ArcelorMittal, said:*

“Closing the acquisition of Ilva is an important strategic step for ArcelorMittal. Ilva is a quality asset that provides a unique opportunity to expand and strengthen our European presence by acquiring Europe’s single-largest steelmaking site. It is a compelling value creation opportunity for ArcelorMittal, that fits our objective of selectively investing in growth projects where we can leverage our operating expertise to grow Ebitda and free cash flow over the long-term.

“We have a strong history of rehabilitating under-performing assets. I am confident that we will prove successful in restoring Ilva’s operational, financial and environmental performance and, in doing so, create value for our company, Ilva’s stakeholders and the Italian economy.”

*Aditya Mittal, Group President and CFO, and CEO, ArcelorMittal Europe, added:*

“It is a great pleasure to welcome Ilva to ArcelorMittal. We are excited by Ilva’s potential; it is a complementary fit with our existing flat products business in Europe, provides significant scale and is strategically well located. Combining this with our steelmaking expertise, technological prowess, and the extensive investment commitments we have made will enable us to positively transform Ilva’s performance.

“Our environmental, industrial and commercial business plans detail how we will turnaround the Ilva business. The cornerstone of our investment commitments is a €1.15 billion environmental investment programme. Work has already begun, and, over time, I am confident we will deliver on our vision of transforming Ilva into one of Europe’s leading and responsible steel manufacturers.

“Given Ilva’s history it is also critical to rebuild trust with local stakeholders through open and transparent dialogue and by demonstrating to them the positive difference that our significant environmental commitments will bring.”

*ENDS*

*About ArcelorMittal *

ArcelorMittal is the world's leading steel and mining company, with a presence in 60 countries and an industrial footprint in 18 countries. Guided by a philosophy to produce safe, sustainable steel, we are the leading supplier of quality steel in the major global steel markets including automotive, construction, household appliances and packaging, with world-class research and development and outstanding distribution networks.

Through our core values of sustainability, quality and leadership, we operate responsibly with respect to the health, safety and wellbeing of our employees, contractors and the communities in which we operate.

For us, steel is the fabric of life, as it is at the heart of the modern world from railways to cars and washing machines. We are actively researching and producing steel-based technologies and solutions that make many of the products and components people use in their everyday lives more energy efficient.

We are one of the world’s five largest producers of iron ore and metallurgical coal. With a geographically diversified portfolio of iron ore and coal assets, we are strategically positioned to serve our network of steel plants and the external global market. While our steel operations are important customers, our supply to the external market is increasing as we grow.

In 2017, ArcelorMittal had revenues of $68.7 billion and crude steel production of 93.1 million metric tonnes, while own iron ore production reached 57.4 million metric tonnes.

ArcelorMittal is listed on the stock exchanges of New York (MT), Amsterdam (MT), Paris (MT), Luxembourg (MT) and on the Spanish stock exchanges of Barcelona, Bilbao, Madrid and Valencia (MTS).

For more information about ArcelorMittal please visit: http://corporate.arcelormittal.com/   
*Contact information ArcelorMittal Investor Relations*  
   
Europe +44 20 7543 1156
Americas +1 312 899 3985
Retail +44 20 7543 1156
SRI +44 207543 1156
Bonds/Credit +33 171 921 026
   
   
*Contact information ArcelorMittal Corporate Communications*  
 

E-mail:  

press@arcelormittal.com
Phone: +442076297988
   
   
*ArcelorMittal Corporate Communications*  
   
Paul Weigh +44 20 3214 2419
Richard Farnsworth +44 20 3214 2882
   
    Reported by GlobeNewswire 19 minutes ago.
↧

MARIMEKKO SEEKS TO ACCELERATE PROFITABLE GROWTH AND TO IMPROVE CAPITAL EFFICIENCY, PROPOSES DISTRIBUTION OF AN ADDITIONAL DIVIDEND OF EUR 1.25 PER SHARE, AS WELL AS REVISES ITS FINANCIAL GOALS

October 31, 2018, 11:06 pm
$
0
0
Marimekko Corporation, Stock Exchange Release, 1 November 2018 at 8 a.m.

*MARIMEKKO SEEKS TO ACCELERATE PROFITABLE GROWTH AND TO IMPROVE CAPITAL EFFICIENCY, PROPOSES DISTRIBUTION OF AN ADDITIONAL DIVIDEND OF EUR 1.25 PER SHARE, AS WELL AS REVISES ITS FINANCIAL GOALS*

The sale of Marimekko’s head office in April 2018 strengthened the company’s financial position. In its half-year financial report published on 9 August 2018, Marimekko stated that, in the autumn, the company’s Board of Directors will examine various options to use the funds obtained from the transaction. In this evaluation, the Board has focused on accelerating profitable growth and improving capital efficiency.

The Board of Directors has decided that part of the funds will be used for development of strategically important business areas and that a proposal for the payment of an additional dividend will be made to the Annual General Meeting to be held in spring 2019. At the same time, the Board has examined the company’s long-term financial goals and decided to revise the goals related to profitability and capital structure.

*Part of the funds to be used for accelerating profitable growth*

Marimekko sold and leased back its head office in spring 2018 to be able to focus on the development of the company’s core business. The company has also announced that, in the coming years, it will seek clearly stronger growth than before. As part of its evaluation, the Board of Directors has now decided that part of the funds obtained from the sale of the head office will be used for development of strategically important business areas. The aim of these initiatives is to accelerate customer base expansion by continuing the development of the brand and the collections and by investing in digital business, omnichannel operations, IT systems and growth in Asia.

*The Board will propose to the Annual General Meeting distribution of an additional dividend*

In the view of Marimekko’s Board of Directors, the company’s strong financial position allows the distribution of an additional dividend. Furthermore, the Board has paid special attention to improving capital efficiency. Thus, the Board will propose to the Annual General Meeting to be held in spring 2019 that an extra dividend of EUR 1.25 per share be paid. The Annual General Meeting is planned to be held on Wednesday 17 April 2019. The Board will publish a notice of the Annual General Meeting and the proposals to the Meeting (including a proposal for the regular annual dividend) according to the normal schedule in early 2019.

*The company revises its long-term financial goals*

As part of its evaluation, Marimekko’s Board of Directors has also decided to revise the long-term goals related to the company’s profitability and capital structure. The updated financials goals are as follows:

· annual growth in net sales over 10% (unchanged)
· operating profit margin 15% (earlier: 10%)
· ratio of net debt to EBITDA at year end max. 2 (new)
· the intention is to pay a yearly dividend; percentage of earnings per share allocated to dividends at least 50% (unchanged)

*Further information:*
Tiina Alahuhta-Kasko, President and CEO, tel. +358 9 758 71
Elina Anckar, CFO, tel. +358 9 758 7261

MARIMEKKO CORPORATION
Board of Directors

DISTRIBUTION:
Nasdaq Helsinki Ltd
Key media

Marimekko is a Finnish design company renowned for its original prints and colours. The company’s product portfolio includes high-quality clothing, bags and accessories as well as home décor items ranging from textiles to tableware. When Marimekko was founded in 1951, its unparalleled printed fabrics gave it a strong and unique identity. Marimekko products are sold in about 40 countries. In 2017, brand sales of the products worldwide amounted to EUR 193 million and the company's net sales were EUR 102 million. Roughly 150 Marimekko stores serve customers around the globe. The key markets are Northern Europe, North America and the Asia-Pacific region. The Group employs about 450 people. The company’s share is quoted on Nasdaq Helsinki Ltd. www.marimekko.com Reported by GlobeNewswire 19 minutes ago.
↧
Viewing all 65275 articles
Browse latest View live
More Pages to Explore .....
Search

Latest Images

New private rooms on Tokaido Shinkansen change the way we travel from Tokyo...

New private rooms on Tokaido Shinkansen change the way we travel from Tokyo...

April 22, 2024, 6:00 am
Ukraine bans military from online gambling amid addiction concerns

Ukraine bans military from online gambling amid addiction concerns

April 22, 2024, 5:17 am
ಮಂಡ್ಯದಿಂದ ಸುಮಲತಾ ದೂರ; ಹೆಚ್‌ಡಿಕೆ ಪರ ಪ್ರಚಾರಕ್ಕಿಳಿಯದ ಸಂಸದೆ –ಬರ್ತಾರೆ ನೋಡೋಣ ಎಂದ...

ಮಂಡ್ಯದಿಂದ ಸುಮಲತಾ ದೂರ; ಹೆಚ್‌ಡಿಕೆ ಪರ ಪ್ರಚಾರಕ್ಕಿಳಿಯದ ಸಂಸದೆ –ಬರ್ತಾರೆ ನೋಡೋಣ ಎಂದ...

April 20, 2024, 8:08 pm
OCBC Bank Singapore Offers Up to 2.8% p.a. Fixed Deposit Promotion from 21...

OCBC Bank Singapore Offers Up to 2.8% p.a. Fixed Deposit Promotion from 21...

April 20, 2024, 12:38 pm
National Poetry Month 2024: Maxine Starr

National Poetry Month 2024: Maxine Starr

April 19, 2024, 9:56 am
Vegan Chicken Pot Pie

Vegan Chicken Pot Pie

April 19, 2024, 9:18 am
Firefox UX: On Purpose: Collectively Defining Our Team’s Mission Statement

Firefox UX: On Purpose: Collectively Defining Our Team’s Mission Statement

April 19, 2024, 7:03 am
New $4.5 million East Bay trail path will connect bicyclists, pedestrians to...

New $4.5 million East Bay trail path will connect bicyclists, pedestrians to...

April 18, 2024, 11:05 am
Photographer Gifts for Clients / Print Packaging / 4x6 Photo Box by...

Photographer Gifts for Clients / Print Packaging / 4x6 Photo Box by...

April 17, 2024, 6:48 pm
Deepfake Video of Aamir Khan circulates Online

Deepfake Video of Aamir Khan circulates Online

April 17, 2024, 3:07 am